Malpractice News: Drug firms must pay Alabama $114 million
Malpractice News: On July 1, 2008 the Associated Press reported that the Court in Montgomery, Alabama found GlaxoSmithKline and Novartis defrauded Alabama in a Medicaid drug pricing scheme and ordered the firms to pay more than $114 million in damages.
In the jury’s second day of deliberations, they found that the GlaxoSmithKline should pay $80.8 million in compensatory damages, and Novartis should pay about $33.7 million. The jury did not order punitive damages. In a separate case tried in February 2008, a jury awarded the state $215 million against AstraZeneca Pharmaceuticals LP; however, the judge later reduced that verdict to $160 million. Our medical malpractice lawyers are here to help you.If you have been harmed by a health professional, please complete the form below for a free medical malpractice lawsuit review. A representative of our firm will be in touch shortly.
see also:
Ohio Health Center malpractice charge
Ohio health center faces malpractice lawsuit over wrong diagnosisOhio University woman misdiagnosed twice in one day; cries malpractice
Massachusetts Supreme Court decision
Massachusetts court favors injured in medical malpractice awardsMassachusetts court recognizes victims' rights in medical malpractice
Breaking News
Doctor/Nurse Medical Malpractice Injury Lawsuit Info: Breaking News Medical Malpractice Injury Information: FREE Research: Breaking News
